Day

MD Esthetics Announces Expansion Outside of New England

Retrieved on: 
Friday, April 5, 2024
Health, Weight loss, Female, Acquisition, MD, Wellness, Day, Aesthetics

WINDHAM, N.H., April 4, 2024 /PRNewswire/ -- MD Esthetics is excited to announce the acquisition of three new locations.

Key Points: 
  • WINDHAM, N.H., April 4, 2024 /PRNewswire/ -- MD Esthetics is excited to announce the acquisition of three new locations.
  • MD Esthetics, LLC is a premier medical aesthetics brand comprising ten corporate and one franchisee-owned location.
  • Adding on to the existing portfolio of locations in New England is the acquisition of Marino Health and Wellness in Londonderry, NH.
  • According to MD Esthetics COO Danielle Pedro "The team at Marino has built a strong business focused on wellness, pain-management, female health, and weight loss.

OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101

Retrieved on: 
Friday, March 22, 2024
Day, Ora, Dry, NCP, Conjunctiva, BID, Physiology, Patient, Pain, Ophthalmology, Observation, Blurred Vision, Doctor of Philosophy, Itch, DED, MOA, Safety, Screen time, Telecanthus, Medical director, FDA, Pharmaceutical industry

Ocular Pain Relief showed statistically significant improvement as early as day 15 and the benefit was durable throughout the trial.

Key Points: 
  • Ocular Pain Relief showed statistically significant improvement as early as day 15 and the benefit was durable throughout the trial.
  • Tear Film Break-up Time showed statistically significant improvement as early as day 15 with the benefit durable for the remainder of the trial.
  • Burning/Stinging, and Blurred Vision improved as early as day 15 and the benefit remained durable throughout the trial.
  • Significant improvements were observed across multiple symptoms as measured in a daily symptom diary including pain, burning/stinging, eye dryness and itching within the first two weeks of treatment.

Captain Planet Foundation Raises More Than $800,000 at Annual Gala Honoring Environmental Heroes Josh Bernstein and Oluwaseyi Moejoh

Retrieved on: 
Sunday, March 17, 2024
Cox Media Group, Lindblad, History, Genuine Parts Company, Into, Georgia Aquarium, Gala, NFL, Corporate responsibility, HRH, The Coca-Cola Company, NASA, Eurosport 1, Chef, Climate change, Knowledge, Cat, Superhero, Student, STEM, Discovery, Francis Ford, Environment, Cox Enterprises, School, Social impact, Environmental justice, Atlanta Gas Light, Ray, Day, Unknown, Delta Air Lines

ATLANTA, March 17, 2024 (GLOBE NEWSWIRE) -- Last night, Captain Planet Foundation, the global non-profit, held their annual Gala at Flourish Atlanta and recognized environmental heroes, Josh Bernstein and Oluwaseyi Moejoh. Additionally, Cox Enterprises received the Corporate Superhero for the Earth Award. The benefit raised more than $800,000 to support the Foundation’s worldwide educational programming and grant-making efforts to engage and empower young people to be problem solvers for the planet. The Gala was hosted by Atlanta Journal-Constitution’s The Monica Pearson Show host, Monica Kaufman Pearson.

Key Points: 
  • ATLANTA, March 17, 2024 (GLOBE NEWSWIRE) -- Last night, Captain Planet Foundation , the global non-profit, held their annual Gala at Flourish Atlanta and recognized environmental heroes, Josh Bernstein and Oluwaseyi Moejoh.
  • The Gala was hosted by Atlanta Journal-Constitution’s The Monica Pearson Show host, Monica Kaufman Pearson.
  • More than 400 guests were in attendance to celebrate the honorees and the impact that Captain Planet Foundation has had on youth around the world.
  • Captain Planet Foundation also introduced the Laura Turner Seydel Legacy Fund which will support the Planeteer Alliance, additional scholarships, and programing for the Foundation.

Qifu Technology Announces Fourth Quarter and Full Year 2023 Unaudited Financial Results, Declares Semi-Annual Dividend and Announces a New Share Repurchase Plan

Retrieved on: 
Tuesday, March 12, 2024
PIN, Tax, Software as a service, Risk management, Growth, Environment, Partnership, Day, Risk, Shop, Internet, Policy, Acquisition, Table, ADS, ICE, ABS, Cloud computing, GAAP, Calendar, Collection, Share repurchase, Marketing, Cryptocurrency

SHANGHAI, China, March 12, 2024 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2023, declared semi-annual dividend and announced a new share repurchase plan.

Key Points: 
  • Under other technology solutions, we offer financial institutions on-premise deployed, modular risk management SaaS, which helps financial institution partners improve credit assessment results.
  • Loan facilitation volume through other technology solutions was RMB 29,705 million in the fourth quarter of 2023.
  • Non-GAAP income from operations was RMB1,322.1 million (US$186.2 million), compared to RMB995.2 million in the same period of 2022.
  • Net income attributed to the Company was RMB1,111.7 million (US$156.6 million), compared to RMB872.0 million in the same period of 2022.

Forge Global Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results

Retrieved on: 
Tuesday, March 26, 2024
Finance, Professional Services, Technology, Fintech, Software, Forecasting, Day, Acquisition, Table, Trust, Adjustment, Arhopala, Annual report, Depreciation, GAAP, ID, Cryptocurrency

Forge Global Holdings, Inc. (“Forge,” or the “Company”) (NYSE: FRGE), a leading private securities marketplace, today announced its financial results for the quarter and year ended December 31, 2023.

Key Points: 
  • Forge Global Holdings, Inc. (“Forge,” or the “Company”) (NYSE: FRGE), a leading private securities marketplace, today announced its financial results for the quarter and year ended December 31, 2023.
  • Operating Income: Total operating loss went from $21.5 million in the quarter ended September 30, 2023 to $24.4 million in the quarter ended December 31, 2023.
  • Net Loss: Net loss went from $19.0 million in the quarter ended September 30, 2023 to $26.2 million in the quarter ended December 31, 2023.
  • Adjusted EBITDA: Total adjusted EBITDA loss went from $10.4 million in the quarter ended September 30, 2023 to $13.6 million in the quarter ended December 31, 2023.

Boulevard Launches New Capital Program Designed Specifically for Self-Care Businesses

Retrieved on: 
Wednesday, March 20, 2024
Professional Services, Cosmetics, Retail, Small Business, Technology, Software, Finance, United States Census Bureau, Growth, Annual business survey (UK), Credit, Small business, Investment, Precision, Day, Marketing, Bank

Boulevard ( www.joinblvd.com ), provider of the client experience platform purpose-built for appointment-based, self-care businesses, today announced the launch of Boulevard Capital.

Key Points: 
  • Boulevard ( www.joinblvd.com ), provider of the client experience platform purpose-built for appointment-based, self-care businesses, today announced the launch of Boulevard Capital.
  • Based on demonstrated business performance rather than credit history, Boulevard Capital offers self-care business owners the fast, flexible funding they need to reinvest in their businesses and drive continued growth.
  • “For years, the self-care industry has been underserved by lenders who understand little to nothing about how these unique businesses work,” said Matt Danna, co-founder and CEO of Boulevard.
  • Boulevard Capital addresses this challenge by providing eligible customers with fast, flexible funding to make critical investments in their businesses.

Creditsafe Releases Financial & Bankruptcy Outlook for U.S. Transportation

Retrieved on: 
Thursday, March 14, 2024
Professional Services, Business, Data Analytics, Transportation, Finance, Travel, Financial management, Day, Bankruptcy, Risk management, Growth, Spirit Airlines, Transport, Landstar System, Intelligence, Yellow Corporation, Acquisition, Avis Budget Group, The Hertz Corporation, J. B. Hunt, Accounts payable, DBT, Avis, FedEx, XPO, Airline

These challenges have created a pressure-cooker situation, driving companies like Yellow Corporation and Hertz Global Holdings to file for bankruptcy.

Key Points: 
  • These challenges have created a pressure-cooker situation, driving companies like Yellow Corporation and Hertz Global Holdings to file for bankruptcy.
  • Today, Creditsafe , the global expert in credit monitoring and risk management, released its Financial & Bankruptcy Outlook: Transportation report , which examines how financial planning, cash flow management and Accounts Payable management have affected the financial health of U.S. transportation and warehousing businesses.
  • The data included in the report was gathered from multiple sources, including financial earnings reports released by the companies, filings with the U.S. Securities and Exchange Commission and the Creditsafe credit risk and intelligence platform .
  • XPO, Inc. is in strong financial shape: XPO’s DBT (Days Beyond Terms) has consistently dropped since August, indicating an improvement in its cash flow and financial management practices.

Acara Partners to Exhibit at AmSpa's Medical Spa Show 2024 in Las Vegas

Retrieved on: 
Wednesday, March 27, 2024
Booth, Partner, Day, Marketing, Consultant, Business development, Wynn Las Vegas

BRANFORD, Conn., March 27, 2024 /PRNewswire-PRWeb/ -- Acara Partners, a full-service business consulting and marketing agency for the aesthetic medical industry, will be exhibiting at The Medical Spa Show from April 11-14, 2024, in Las Vegas. Returning to AmSpa's annual event for the fifth time, Acara Partners will be located at Booth #433 at Wynn Las Vegas.

Key Points: 
  • Acara Partners, one of the aesthetic medical industry's premier business consulting and marketing agencies, will exhibit at AmSpa's The Medical Spa Show 2024 in Las Vegas from April 11-14.
  • BRANFORD, Conn., March 27, 2024 /PRNewswire-PRWeb/ -- Acara Partners, a full-service business consulting and marketing agency for the aesthetic medical industry, will be exhibiting at The Medical Spa Show from April 11-14, 2024, in Las Vegas.
  • Returning to AmSpa's annual event for the fifth time, Acara Partners will be located at Booth #433 at Wynn Las Vegas.
  • AmSpa attendees, visit Acara Partners at Booth #433 for these special offers:
    To learn more or to set up a meeting with Acara Partners in Las Vegas, please call 203.488.0028.

Serotonin Anti-Aging Centers to Debut in Chicagoland with 3-Unit Development Deal

Retrieved on: 
Thursday, March 21, 2024
Health, Collagen induction therapy, Elective surgery, Economic development, Overalls, PRP, Hormone replacement therapy, Happiness, HRT, Day, Map, HBOT, Fast food

CHICAGO, March 21, 2024 /PRNewswire/ -- Serotonin Anti-Aging Centers announced today the upcoming opening of three new locations in the Chicago suburbs. The nation's fastest growing anti-aging/longevity franchise plans to open the doors to its first location in DuPage County within the year.

Key Points: 
  • CHICAGO, March 21, 2024 /PRNewswire/ -- Serotonin Anti-Aging Centers announced today the upcoming opening of three new locations in the Chicago suburbs.
  • When searching for new business opportunities, Aboobaker was drawn toward optimizing the health of Chicagoland residents with the science-backed services of Serotonin.
  • "Awarding this franchise to Pilakka is a fantastic opportunity for the Serotonin brand national footprint," said Eric Casaburi, Founder and CEO of Serotonin Anti-Aging Centers.
  • To learn more about Serotonin Anti-Aging Centers and its franchising opportunities, visit www.serotonincenters.com/franchising/ .

BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment

Retrieved on: 
Friday, February 23, 2024
Incidence, AAAAI, Pharmacy, Attack, Expert network, Tranexamic acid, Prior, Effectiveness, Pharmacist, Washington Convention Center, University, Conditional sentence, Day, Lanadelumab, Safety, Androgen, HAE, History, Hereditary angioedema, Tolerability, Monitoring, Internal medicine, Walter, BioCryst Pharmaceuticals, Medicine, Disease, Ageing, Observational study, Poster, American Academy, Pharmaceutical industry

“These additional analyses of real-world use of ORLADEYO show that any person living with HAE has the potential to experience a rapid, substantial and sustained reduction in their monthly attack rate with ORLADEYO.

Key Points: 
  • “These additional analyses of real-world use of ORLADEYO show that any person living with HAE has the potential to experience a rapid, substantial and sustained reduction in their monthly attack rate with ORLADEYO.
  • These analyses present the overall attack rate progression and attack rate progression stratified by severity (i.e., number of attacks at baseline), prior prophylaxis and C1-INH level and function.
  • These findings further demonstrate that ORLADEYO can help maintain disease control in patients with lower baseline attack rates and further reduce attack rates in patients with more active disease.
  • Berotralstat Prophylaxis Reduces HAE Attack Rates Regardless of Baseline Attacks: Real-World Outcomes; Poster #012; Friday, February 23, 3:15-4:15 p.m.